BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Bio NC

  Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - May 08, 2023

  Precision BioSciences, Inc. announced that, on April 27, 2023, the Compensation Committee of Precision’s Board of Directors approved the grant of inducement awards to new employees under the Precision BioSciences, Inc. 2021 Employment Inducement Incentive Award Plan.

  May 8, 2023

   · 

  1 min read
• Business

  Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2023 Financial Results

  Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today provides a business update and announces financial results for the first quarter of 2023.

  May 8, 2023

   · 

  6 min read
• Business

  Viemed Healthcare Announces First Quarter 2023 Financial Results

  Viemed Healthcare, Inc., a national leader in respiratory care and technology-enabled home medical equipment services, announced its financial results for the three months ended March 31, 2023.

  May 8, 2023

   · 

  15 min read
• Ochre Bio to Participate in Upcoming Global Industry Conferences - May 09, 2023

  Ochre Bio, an innovator in chronic liver disease medicine development, has announced its participation in upcoming investor and industry conferences, sharing expert perspectives and insights across liver disease and RNA therapeutics, building and scaling startups, and the future of medicine.

  May 8, 2023

   · 

  1 min read
• Industry Survey Identifies Successful Biotech Clinical Trial Strategies

  Novotech, the leading Asia Pacific centred biotech CRO conducted a survey of global biotech professionals, in partnership with Citeline, on their current and future clinical pipeline prospects, the main challenges of clinical trials, and perspective shifts regarding study locations.

  May 8, 2023

   · 

  2 min read